Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 302

The DOI matches its Crossref record.

FAPI-74 PET/CT Using Either18F-AlF or Cold-Kit68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients

Open access
Giesel, Frederik L., Adeberg, Sebastian, Syed, Mustafa, Lindner, Thomas, Jiménez-Franco, Luis David, Mavriopoulou, Eleni, Staudinger, Fabian, Tonndorf-Martini, Eric, Regnery, Sebastian, Rieken, Stefan, El Shafie, Rami, Röhrich, Manuel, Flechsig, Paul, Kluge, Andreas, Altmann, Annette, Debus, Jürgen, Haberkorn, Uwe, Kratochwil, Clemens·2021·Journal of Nuclear Medicine

Abstract

68Ga-fibroblast activation protein inhibitors (FAPIs) 2, 4, and 46 have already been proposed as promising PET tracers. However, the short half-life of 68Ga (68 min) creates problems with manufacture and delivery. 18F (half-life, 110 min) labeling would result in a more practical large-scale production, and a cold-kit formulation would improve the spontaneous availability. The NOTA chelator ligand FAPI-74 can be labeled with both 18F-AlF and 68Ga. Here, we describe the in vivo evaluation of 18F-FAPI-74 and a proof of mechanism for 68Ga-FAPI-74 labeled at ambient temperature. Methods: In 10 patients with lung cancer, PET scans were acquired at 10 min, 1 h, and 3 h after administration of 259 ± 26 MBq of 18F-FAPI-74. Physiologic biodistribution and tumor uptake were semiquantitatively evaluated on the basis of SUV at each time point. Absorbed doses were evaluated using OLINDA/EXM, version 1.1, and QDOSE dosimetry software with the dose calculator IDAC-Dose, version 2.1. Identical methods were used to evaluate one examination after injection of 263 MBq of 68Ga-FAPI-74. Results: The highest contrast was achieved in primary tumors, lymph nodes, and distant metastases at 1 h after injection, with an SUVmax of more than 10. The effective dose per a 100-MBq administered activity of 18F-FAPI-74 was 1.4 ± 0.2 mSv, and for 68Ga-FAPI-74 it was 1.6 mSv. Thus, the radiation burden of a diagnostic 18F-FAPI-74 PET scan is even lower than that of PET scans with 18F-FDG and other 18F tracers; 68Ga-FAPI-74 is comparable to other 68Ga ligands. FAPI PET/CT supported target volume definition for guiding radiotherapy. Conclusion: The high contrast and low radiation burden of FAPI-74 PET/CT favor multiple clinical applications. Centralized large-scale production of 18F-FAPI-74 or decentralized cold-kit labeling of 68Ga-FAPI-74 allows flexible routine use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2967/jnumed.120.245084

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 302

Metadata

Authors
Giesel, F. L., Adeberg, S., Syed, M., Lindner, T., Jiménez-Franco, L. D., Mavriopoulou, E., Staudinger, F., Tonndorf-Martini, E., Regnery, S., Rieken, S., El Shafie, R., Röhrich, M., Flechsig, P., Kluge, A., Altmann, A., Debus, J., Haberkorn, U., & Kratochwil, C.
Venue
Journal of Nuclear Medicine
Published
2020-06-26
Volume
62
Issue
2
Pages
201-207
ISSN
  • 0161-5505 (ISSN-L)
  • 2159-662X
OpenAlex
W3037670955
Cited by
302
References
0
FWCI
17.26
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: FAPI-74 PET/CT Using Either18F-AlF or Cold-Kit68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients. https://app.cochat.ai/papers/10.2967/jnumed.120.245084
The paper
Giesel, F. L., Adeberg, S., Syed, M., Lindner, T., Jiménez-Franco, L. D., Mavriopoulou, E., Staudinger, F., Tonndorf-Martini, E., Regnery, S., Rieken, S., El Shafie, R., Röhrich, M., Flechsig, P., Kluge, A., Altmann, A., Debus, J., Haberkorn, U., & Kratochwil, C. (2021). FAPI-74 PET/CT Using Either18F-AlF or Cold-Kit68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.120.245084

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.